When a drug is investigational, access usually depends on a study protocol, trial site participation, inclusion criteria, exclusion criteria, consent forms, and scheduled follow-up
A high-quality care experience should include: Comprehensive lab testing Insurance navigation or access to patient assistance programs Education and monitoring for common side effects and how to respond if they occur Use of technology like continuous glucose monitors (CGMs), smart scales, or blood pressure monitors to track progress Ongoing guidance for lifestyle supportincluding nutrition, movement, and habit-building to get the most benefit from medication These medications can be transformative, but only when matched thoughtfully to a persons unique health profile
Shatavari enhances libido and rejuvenates female reproductive potential by promoting general well-being and/or support in counterbalancing day-to-day environmental stress[27,40]
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist widely explored in laboratory and experimental research settings related to metabolic regulation, glucose-homeostasis pathways, appetite-related signaling, and adipose-related research models
The decision to cover GLP-1s with approved weight loss indications requires careful consideration by plan fiduciaries and will be personal for each plan